Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysis
Clicks: 1
ID: 328605
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #356 of 357 articles by views in JNCI Journal of the National Cancer Institute
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 357 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Epidemiologic studies of PFAS and liver cancer risk have produced conflicting results with no strong or clear associations for pre-diagnostic perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorohexanesulfonate (PFHxS). We now report analyses of nine additional PFAS in a nested case-control study within 12 prospective cohorts (853 cases, 853 matched controls) in the United States. Using multivariable-adjusted conditional logistic regression, we estimated odds ratios per 90th vs. 10th percentile increase in PFAS levels. Perfluoroheptanoic acid (PFHpA) was positively associated with liver cancer risk (OR: 1.78, 95% CI: 1.26–2.52); no associations were observed for other PFAS. Significant heterogeneity was observed by sex, cancer subtype, and time from blood collection. Associations were stronger among males (OR: 3.72, 95% CI: 2.10–6.59), for hepatocellular carcinoma (4.53, 2.59–7.94), and for those diagnosed ≤10 years after blood collection (3.17, 1.80–5.57). Given continued use of short-chain PFAS in consumer products, further research on their effects on liver health is warranted.
| Reference Key |
openalex_W7213440686
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Cody Z. Watling, Jessica L. Petrick, Barry I. Graubard, Hyokyoung G. Hong, Xuehong Zhang, Matthew J Barnett, Mollie E. Barnard, Yu Chen, A Heather Eliassen, J Michael Gaziano, Wen‐Yi Huang, Jae H Kang, Jill Koshiol, I-Min Lee, Erikka Loftfield, Steven C Moore, Lorelei A Mucci, Marian L Neuhouser, Christina C. Newton, Howard D Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Triplette Matthew, Caroline Y. Um, Kala Visvanathan, Jean Wactawski‐Wende, Eleanor L. Watts, Walter C Willett, Fen Wu, Wei Zheng, Peter T. Campbell, Jonathan N Hofmann, Mark P. Purdue, DINESH BARUPAL, Katherine A. McGlynn |
| Journal | JNCI Journal of the National Cancer Institute |
| Year | 2026 |
| DOI |
10.1093/jnci/djag325
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.